HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hwei-Chung Wang Selected Research

Urinary Bladder Neoplasms (Bladder Cancer)

6/2011Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan.
12/2009Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hwei-Chung Wang Research Topics

Disease

27Breast Neoplasms (Breast Cancer)
05/2021 - 01/2008
14Neoplasms (Cancer)
05/2018 - 04/2008
5Neoplasm Metastasis (Metastasis)
09/2014 - 01/2012
4Triple Negative Breast Neoplasms
05/2021 - 01/2014
3Carcinogenesis
05/2021 - 01/2014
2Hand-Foot Syndrome
06/2018 - 12/2014
2Urinary Bladder Neoplasms (Bladder Cancer)
06/2011 - 12/2009
2Genomic Instability
12/2009 - 09/2009
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2017
1Vomiting
03/2016
1Nausea
03/2016
1Alopecia (Baldness)
03/2016
1Mucositis
03/2016
1Neutropenia
12/2014
1Pain (Aches)
09/2014
1Multiple Myeloma
10/2013
1Prostatic Neoplasms (Prostate Cancer)
10/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2012
1Lung Neoplasms (Lung Cancer)
10/2012
1Disease Progression
05/2012
1Neuroendocrine Carcinoma
01/2012
1Stomach Neoplasms (Stomach Cancer)
05/2011
1Colorectal Neoplasms (Colorectal Cancer)
08/2010

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2008
4DNA (Deoxyribonucleic Acid)IBA
05/2011 - 09/2009
3AnthracyclinesIBA
06/2018 - 12/2014
31-dodecylpyridoxal (PLD)IBA
06/2018 - 12/2014
3liposomal doxorubicin (Doxil)FDA Link
06/2018 - 12/2014
3Matrix Metalloproteinases (MMPs)IBA
05/2018 - 01/2017
3Zoledronic Acid (Zometa)FDA Link
09/2014 - 10/2013
3Caveolin 1IBA
10/2011 - 08/2010
2Estrogen ReceptorsIBA
09/2016 - 01/2012
2Cisplatin (Platino)FDA LinkGeneric
05/2012 - 06/2011
2Docetaxel (Taxotere)FDA Link
05/2012 - 06/2011
2Hormones (Hormone)IBA
01/2012 - 06/2011
2Tumor Biomarkers (Tumor Markers)IBA
01/2012 - 09/2011
2exodeoxyribonuclease IIBA
12/2009 - 09/2009
2Codon (Codons)IBA
12/2009 - 01/2008
1Interleukin-10 (Interleukin 10)IBA
05/2021
1Interleukin-13IBA
12/2020
1Epirubicin (Ellence)FDA LinkGeneric
06/2018
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
05/2018
1Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
01/2018
1ORALIT (ORS)IBA
01/2017
1Nuclear Proteins (Protein, Nuclear)IBA
01/2017
1EnzymesIBA
01/2017
1Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2017
1Estradiol (Delestrogen)FDA LinkGeneric
09/2016
1TamoxifenFDA LinkGeneric
09/2016
1Goserelin (Zoladex)FDA Link
09/2016
1Proteins (Proteins, Gene)FDA Link
03/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2016
1Metalloproteases (Metalloproteinases)IBA
03/2016
1Tissue Inhibitor of Metalloproteinase-1IBA
03/2016
1Antineoplastic Agents (Antineoplastics)IBA
12/2014
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2014
1Estrogens (Estrogen)FDA Link
08/2014
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
08/2014
1Cyclin D1IBA
01/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2012
1Trastuzumab (Herceptin)FDA Link
05/2012
1ProgesteroneFDA LinkGeneric
01/2012
1Letrozole (Femara)FDA LinkGeneric
01/2012
1Carcinoembryonic AntigenIBA
01/2012
1ChromograninsIBA
01/2012
14-chloronitrobenzene (PNCB)IBA
01/2012
1SynaptophysinIBA
01/2012
1NucleotidesIBA
10/2011
13-methylcytidineIBA
09/2011
1NucleosidesIBA
09/2011
1InosineFDA Link
09/2011
1CytidineIBA
09/2011
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
09/2011
1alpha-Crystallin B ChainIBA
09/2011
1Capecitabine (Xeloda)FDA Link
06/2011
1Fluorouracil (Carac)FDA LinkGeneric
04/2008
1Thymidylate SynthaseIBA
04/2008

Therapy/Procedure

6Therapeutics
05/2018 - 06/2011
4Drug Therapy (Chemotherapy)
06/2018 - 04/2008
3Adjuvant Chemotherapy
06/2018 - 12/2014
2Neoadjuvant Therapy
05/2012 - 06/2011
1Mastectomy (Mammectomy)
11/2013